Downstaging hepatocellular carcinoma prior to liver transplantation

Liver Transplantation

Volumn 11, Issue 12, 2005, Pages 1466-1468

  Gamblin, T Clark ^a   Geller, David A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; EDITORIAL; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER RESECTION; LIVER TRANSPLANTATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM STAGING;

EID: 30444457973     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20528     Document Type: Editorial

References (31)

1. Leong AS-Y. Epidemiology, risk factors, etiology, premalignant lesions and carcinogenesis. In: Leong AS-Y, Liew CT, Lau JWY, Johnson PJ, eds. Hepatocellular Carcinoma. Contemporary Diagnosis, Investigation and Management. London: Arnold; 1999:1-29.
2. Rustgi VK. Epidemiology of hepatocellular carcinoma. Gastroenterol Clin North Am 1987;16:545-551.
3. Ferlay J, Bray J, Pisani P, Parkin DM. GLOBOCAN 2000. Cancer Incidence, Mortality and Prevalence Worldwide, version 1.0. IARC CancerBase 5. Lyon: International Agency for Research on Cancer Press, 2001.
4. Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 1999;19:311-322.
5. Belghiti J, Cortes A, Abdalla EK, Regimbau JM, Prakesh K, Durand F, et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 2003;238:885-892.
6. Pocard M, Sauvanet A, Regimbeau JM, Duwat O, Farges O, Belghiti J. Limits and benefits of exclusive transthoracic hepatectomy approach for patients with hepatocellular carcinoma. Hepatogastroenterology 2002;49:32-35.
7. Cha CH, Ruo L, Fong Y, Jarnagin WR, Shia J, Blumgart LH, et al. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg 2003;238:315-321.
8. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002;235: 373-382.
9. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
10. Figueras J, Jaurrieta E, Valls C, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 1997;25:1485-1489.
11. Oldhafer KJ, Chavan A, Fruhauf NR, et al. Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit? J Hepatol 1998;29:953-959.
12. Majno PE, Adam R, Bismuth H, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997;226:688-703.
13. Roayaie S, Frischer JS, Emre SH, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinoma larger than 5 centimeters. Ann Surg 2002;235:533-539.
14. Pelletier G, Roche A, Ink O, et al. A randomized trial in patients with unresectable hepatocellular carcinoma. J Hepatol 1990;11: 181-184.
15. Ryder SD, Rizzi PM, Metivier E, et al. Chemoembolization with lipiodol and doxombicin: applicability in British patients with hepatocellular carcinoma. Gut 1996;38:125-128.
16. Geschwind JH, Ramsey DE, Choir MA, et al. Chemoembolization of hepatocellular carcinoma. Am J Clin Oncol 2003;26: 344-349.
17. Carr BI. Hepatic artery chemoembolization for advanced stage HCC: experience of 650 patients. Hepatogastroenterology 2002;49:79-86.
18. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164-1171.
19. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:1734-1739.
20. Graziadei IW, Sandmueller H, Waldenberger P, et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003;9:557-563.
21. Goodman M, Geller DA. Radiofrequency ablation of hepatocellular carcinoma. In: Carr B, ed. Hepatocellular Cancer. Totowa, NJ: Humana Press; 2005:171-183.
22. Mazzaferro V, Battiston C, Perrone S, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation. Ann Surg 2004;240:900-909.
23. Yao FY, Kinkhabwala M, LaBerge JM, et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcionoma. J Transpl 2005;5:795-804.
24. United Network for Organ Sharing. Policy 3.6, www.unos.org (accessed December 19, 2004).
25. Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 2004;127(Suppl 1):S261-S267.
26. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcionoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-1403.
27. Marsh JW, Dvorchik I. Liver organ allocation for hepatocellular carcinoma: are we sure? Liver Transpl 2003;9:693-696.
28. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002;8:765-774.
29. Fung J, Marsh W. The quandary over liver transplantation for hepatocellular carcinoma: the greater sin? Liver Transpl 2002;8: 775-777.
30. Jain A, Reyes J, Kashyap P, et al. Long-term survival after liver transplantation in 4000 consecutive patients at a single center. Ann Surg 2000;232:490-500.
31. Marsh JW, Geller DA, Finkelstein SD, et al. Role of liver transplantation for hepatobiliary malignant disorders. Lancet Oncol 2004;5:480-488.